glp-1 weight loss drugs news today leave users low on key nutrients, study finds GLP-1 medications could cut US

The study highlights that after stopping GLP-1 medications, many patients resume treatment or try alternatives, influencing weight management strategies.

Study results: what did they find

Safe, drug-free, non-GMO, USA-made

Recently, the Food and Drug Administration officially approved semaglutide for the treatment of metabolic dysfunction-associated steatohepatitis in adults with moderate-to-advanced fibrosis

Promotes a healthy blood sugar response*: Reducose slows down the breakdown of carbs to reduce post-meal glucose spikes by up to 40%, while Feiolix supports insulin sensitivity and glucose metabolism.

Berberine and GLP-1 are fundamentally different compounds targeting distinct metabolic pathways